Mr. Cohen has served as CEO and member of the board of directors since co-founding Axonics in October 2013. Mr. Cohen is an accredited public company director with over 35 years of experience in leading medical device companies and serving as a board member at a number of private and publicly traded life science companies.
From 2010 to 2012, he served as CEO of Vessix Vascular, a venture capital-backed renal denervation company that was acquired by Boston Scientific in November 2012. Previously, Mr. Cohen spent nearly a decade as Chairman and CEO of Nasdaq-listed Cardiac Science Inc., which was ranked as the fourth-fastest growing company in the US in 2004. Currently, Mr. Cohen serves as the Chairman of the board of directors at BioLife Solutions (Nasdaq: BLFS – preservation media for regenerative medicine) and member of the board of directors at BioVentrix, Inc. (privately-held transcatheter ventricular restoration company).
From June 2013 to April 2020, he served as an independent director, Chair of the compensation committee and member of the audit and nominating committees of Spectrum Pharmaceuticals, Inc. (Nasdaq: SPPI – Oncology drugs). Mr. Cohen also previously served on the boards of two companies that successfully executed an exit transaction in 2017, Zurich-based LifeWatch (LIFE.SW), sold to Biotelemetry (Nasdaq: BEAT); and Colorado-based Syncroness, Inc. (privately-held contract engineering firm), sold to ALTEN Group, a multibillion-dollar French engineering services company.
What is Raymond W. Cohen's net worth?
The estimated net worth of Raymond W. Cohen is at least $13.40 million as of January 31st, 2024. Mr. Cohen owns 188,835 shares of Axonics stock worth more than $13,403,508 as of April 9th. This net worth estimate does not reflect any other investments that Mr. Cohen may own. Additionally, Mr. Cohen receives an annual salary of $1,750,000.00 as Co-Founder, Chief Executive Officer and Director at Axonics. Learn More about Raymond W. Cohen's net worth.
How old is Raymond W. Cohen?
What is Raymond W. Cohen's salary?
How do I contact Raymond W. Cohen?
Has Raymond W. Cohen been buying or selling shares of Axonics?
Raymond W. Cohen has not been actively trading shares of Axonics during the last quarter. Most recently, Raymond W. Cohen sold 35,161 shares of the business's stock in a transaction on Wednesday, January 31st. The shares were sold at an average price of $67.74, for a transaction totalling $2,381,806.14. Following the completion of the sale, the chief executive officer now directly owns 188,835 shares of the company's stock, valued at $12,791,682.90. Learn More on Raymond W. Cohen's trading history.
Who are Axonics' active insiders?
Axonics' insider roster includes Juliet Bakker (Director), Raymond Cohen (Co-Founder, Chief Executive Officer and Director), Danny Dearen (Insider), Alfred Ford, Jr. (Insider), Kari Keese (CFO), Jane Kiernan (Director), Esteban Lopez (Director), Robert Mcnamara (Director), Karen Noblett (Insider), Rinda Sama (COO), and John Woock (CMO). Learn More on Axonics' active insiders.
Are insiders buying or selling shares of Axonics?
During the last year, insiders at the sold shares 1 times. They sold a total of 2,961 shares worth more than $205,523.01. The most recent insider tranaction occured on October, 2nd when CFO Kari Leigh Keese sold 2,961 shares worth more than $205,523.01. Insiders at Axonics own 1.9% of the company.
Learn More about insider trades at Axonics. Information on this page was last updated on 10/2/2024.
